相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does current versus former smoking play a role in the relationship between anxiety and mood disorders and nicotine dependence?
Kristin W. Grover et al.
ADDICTIVE BEHAVIORS (2012)
A Signal Detection Method to Detect Adverse Drug Reactions Using a Parametric Time-to-Event Model in Simulated Cohort Data
Victoria R. Cornelius et al.
DRUG SAFETY (2012)
Modified Prescription-Event Monitoring Studies
Deborah Layton et al.
DRUG SAFETY (2011)
Psychiatric Adverse Events Associated with Varenicline An Intensive Postmarketing Prospective Cohort Study in New Zealand
Mira Harrison-Woolrych et al.
DRUG SAFETY (2011)
Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database
Nadege Rouve et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Does Smoking Cessation Cause Depression and Anxiety? Findings from the ATTEMPT Cohort
Bruce Bolam et al.
NICOTINE & TOBACCO RESEARCH (2011)
Suicidal Behavior and Depression in Smoking Cessation Treatments
Thomas J. Moore et al.
PLOS ONE (2011)
Thoughts and Acts of Aggression/Violence Toward Others Reported in Association with Varenicline
Thomas J. Moore et al.
ANNALS OF PHARMACOTHERAPY (2010)
Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
David J. McLernon et al.
DRUG SAFETY (2010)
Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline A Pooled Analysis
Serena Tonstad et al.
DRUG SAFETY (2010)
Prescription Drugs Associated with Reports of Violence Towards Others
Thomas J. Moore et al.
PLOS ONE (2010)
Nicotine Withdrawal Produces a Decrease in Extracellular Levels of Dopamine in the Nucleus Accumbens that is Lower in Adolescent Versus Adult Male Rats
Luis A. Natividad et al.
SYNAPSE (2010)
Hypoglycaemia with Oral Antidiabetic Drugs Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide
Veronika Vlckova et al.
DRUG SAFETY (2009)
Varenicline A Novel Pharmacotherapy for Smoking Cessation
Carlos Jimenez-Ruiz et al.
DRUGS (2009)
Mood, Side-effects and Smoking Outcomes Among Persons With and Without Probable Lifetime Depression Taking Varenicline
Jennifer B. McClure et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample
R. C. Kessler et al.
MOLECULAR PSYCHIATRY (2009)
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database
D. Gunnell et al.
BRITISH MEDICAL JOURNAL (2009)
A randomized, placebo-controlled trial of varenicline, a selective alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers
Shih-Tzu Tsai et al.
CLINICAL THERAPEUTICS (2007)
Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist -: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Nicotine, alcohol and drug dependence, and psychiatric comorbidity - results of a national household survey (Reprinted from British Journal of Psychiatry, vol 179, pgs 432-437, 2001)
M Farrell et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2003)
分享论文
